ScinoPharm Taiwan (Taiwan) Probability of Future Stock Price Finishing Over 27.13

1789 Stock  TWD 22.20  0.50  2.20%   
ScinoPharm Taiwan's future price is the expected price of ScinoPharm Taiwan instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of ScinoPharm Taiwan performance during a given time horizon utilizing its historical volatility. Check out ScinoPharm Taiwan Backtesting, ScinoPharm Taiwan Valuation, ScinoPharm Taiwan Correlation, ScinoPharm Taiwan Hype Analysis, ScinoPharm Taiwan Volatility, ScinoPharm Taiwan History as well as ScinoPharm Taiwan Performance.
  
Please specify ScinoPharm Taiwan's target price for which you would like ScinoPharm Taiwan odds to be computed.

ScinoPharm Taiwan Target Price Odds to finish over 27.13

The tendency of ScinoPharm Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over NT$ 27.13  or more in 90 days
 22.20 90 days 27.13 
near 1
Based on a normal probability distribution, the odds of ScinoPharm Taiwan to move over NT$ 27.13  or more in 90 days from now is near 1 (This ScinoPharm Taiwan probability density function shows the probability of ScinoPharm Stock to fall within a particular range of prices over 90 days) . Probability of ScinoPharm Taiwan price to stay between its current price of NT$ 22.20  and NT$ 27.13  at the end of the 90-day period is close to 99 .
Assuming the 90 days trading horizon ScinoPharm Taiwan has a beta of 0.12. This suggests as returns on the market go up, ScinoPharm Taiwan average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ScinoPharm Taiwan will be expected to be much smaller as well. Additionally ScinoPharm Taiwan has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   ScinoPharm Taiwan Price Density   
       Price  

Predictive Modules for ScinoPharm Taiwan

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ScinoPharm Taiwan. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
21.3122.2023.09
Details
Intrinsic
Valuation
LowRealHigh
22.1923.0723.97
Details

ScinoPharm Taiwan Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ScinoPharm Taiwan is not an exception. The market had few large corrections towards the ScinoPharm Taiwan's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ScinoPharm Taiwan, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ScinoPharm Taiwan within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.15
β
Beta against Dow Jones0.12
σ
Overall volatility
0.82
Ir
Information ratio -0.25

ScinoPharm Taiwan Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ScinoPharm Taiwan for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ScinoPharm Taiwan can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
ScinoPharm Taiwan generated a negative expected return over the last 90 days
About 59.0% of the company shares are owned by insiders or employees

ScinoPharm Taiwan Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ScinoPharm Stock often depends not only on the future outlook of the current and potential ScinoPharm Taiwan's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ScinoPharm Taiwan's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding790.7 M
Dividends Paid395.4 M
Short Long Term Debt1.2 M

ScinoPharm Taiwan Technical Analysis

ScinoPharm Taiwan's future price can be derived by breaking down and analyzing its technical indicators over time. ScinoPharm Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ScinoPharm Taiwan. In general, you should focus on analyzing ScinoPharm Stock price patterns and their correlations with different microeconomic environments and drivers.

ScinoPharm Taiwan Predictive Forecast Models

ScinoPharm Taiwan's time-series forecasting models is one of many ScinoPharm Taiwan's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ScinoPharm Taiwan's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about ScinoPharm Taiwan

Checking the ongoing alerts about ScinoPharm Taiwan for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ScinoPharm Taiwan help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ScinoPharm Taiwan generated a negative expected return over the last 90 days
About 59.0% of the company shares are owned by insiders or employees

Additional Tools for ScinoPharm Stock Analysis

When running ScinoPharm Taiwan's price analysis, check to measure ScinoPharm Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ScinoPharm Taiwan is operating at the current time. Most of ScinoPharm Taiwan's value examination focuses on studying past and present price action to predict the probability of ScinoPharm Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ScinoPharm Taiwan's price. Additionally, you may evaluate how the addition of ScinoPharm Taiwan to your portfolios can decrease your overall portfolio volatility.